SCHEMBL7594754

SCHEMBL7594754

Cn1cc(C2=C(c3c[nH]c4cc(N5CCCC5)ccc34)C(=O)NC2=O)c2ccc(F)cc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 4/20 0.67
CCND1 P24385 4/20 0.67
CCNE2 O96020 3/20 0.67
CCNE1 P24864 3/20 0.67
CDK2 P24941 3/20 0.67
PRKACA P17612 2/20 0.67
PRKACG P22612 2/20 0.67
PRKACB P22694 2/20 0.67
PRKCA P17252 6/20 0.50
JAK3 P52333 5/20 0.50
GSK3B P49841 4/20 0.50
CAMK2D Q13557 2/20 0.47
PRKCB P05771 5/20 0.46
PRKCH P24723 5/20 0.46
PRKCE Q02156 5/20 0.46
PRKCD Q05655 5/20 0.46
PRKCQ Q04759 4/20 0.46
JAK1 P23458 2/20 0.45
PRKCG P05129 1/20 0.45
SRC P12931 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598834 0.93 CDK4 (0.65) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7990781 0.89 IDH1 (0.56) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7597574 0.86 CCNE2 (0.69) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7599053 0.85 CCNE2 (0.51) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7976571 0.83 GSK3B (0.56) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7990993 0.81 CDK2 (0.67) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7986966 0.80 PRKACA (0.66) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7976776 0.78 CDK4 (0.67) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7987101 0.77 CDK4 (0.66) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7524580 0.77 GSK3B (0.58) CDK4CCND1CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US claimed
EP-1242409-A2 SUBSTITUTED BISINDOLYLMALEIMIDES F. HOFFMANN-LA ROCHE AG (CH) 2002-09-25 EP disclosed
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed
WO-2001046178-A2 SUBSTITUIERTE BISINDOLYMALEIMIDE F. HOFFMANN-LA ROCHE AG (CH) 2001-06-28 WO disclosed